Literature DB >> 2678133

Platelet activating factor (PAF) and its role in cardiac injury.

A M Lefer1.   

Abstract

PAF is a phospholipid formed from the action of phospholipase A2 triggered by immunologic or hypoxic stimuli. PAF does not exist in its active form but rather is present as a storage product within cells, and is synthesized rapidly upon appropriate activation. PAF is a potent lipid mediator which is released by a variety of cell types in mammalian systems. PAF appears to be a particularly important mediator of myocardial ischemia and circulatory shock states in mammalian species. Moreover, since PAF releases other lipid mediators, it may have an "amplifier" role in the propagation of circulatory disease states.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2678133

Source DB:  PubMed          Journal:  Prog Clin Biol Res        ISSN: 0361-7742


  3 in total

Review 1.  Hypoxia and inflammatory synovitis: observations and speculation.

Authors:  C R Stevens; R B Williams; A J Farrell; D R Blake
Journal:  Ann Rheum Dis       Date:  1991-02       Impact factor: 19.103

Review 2.  PAF. A review of its effects, antagonists and possible future clinical implications (Part II).

Authors:  M Koltai; D Hosford; P Guinot; A Esanu; P Braquet
Journal:  Drugs       Date:  1991-08       Impact factor: 9.546

3.  Acute inflammatory reaction after myocardial ischemic injury and reperfusion. Development and use of a neutrophil-specific antibody.

Authors:  H K Hawkins; M L Entman; J Y Zhu; K A Youker; K Berens; M Doré; C W Smith
Journal:  Am J Pathol       Date:  1996-06       Impact factor: 4.307

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.